Related Experiment Video
Updated: Jul 17, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Idiopathic interstitial pneumonias: from classification to diagnostic work-up]
C Müller-Mang1, L Stiebellehner, K Schmid
1Universitätsklinik für Radiodiagnostik, Medizinische Universität, Währinger Gürtel 18-20, A-1090, Wien, Austria. christina.mueller-mang@meduniwien.ac.at
Der Radiologe
|January 25, 2007
Summary
Idiopathic interstitial pneumonias (IIP) are rare lung diseases. High-resolution CT imaging aids diagnosis by correlating lung anatomy with histologic patterns, but biopsy is often needed.
Area of Science:
- Pulmonary Medicine
- Radiology
- Pathology
Background:
- Idiopathic interstitial pneumonias (IIP) encompass seven distinct histologic entities.
- While rare, IIPs serve as models for secondary interstitial pneumonias.
- High-resolution computed tomography (HRCT) significantly advanced IIP imaging.
Purpose of the Study:
- To review the computed tomography (CT) patterns of Idiopathic Interstitial Pneumonias (IIP).
- To provide clinical and histological information for radiologists.
- To support the multidisciplinary approach in managing IIP.
Main Methods:
- Review of CT patterns associated with IIP.
- Correlation of CT morphology with histologic findings.
- Integration of clinical context in diagnostic interpretation.
Main Results:
- HRCT allows detailed delineation of lung anatomy, enabling correlation with IIP histologic patterns.
- CT morphology, combined with clinical information, can lead to accurate diagnosis in many IIP cases.
- Significant overlap exists between different IIP entities on CT.
Conclusions:
- Radiologists can achieve accurate IIP diagnoses using HRCT and clinical data.
- Complementary lung biopsy remains essential due to overlapping CT features.
- Understanding CT patterns is crucial for radiologists in the multidisciplinary care of IIP.
Related Concept Videos
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: